GPBAR1 and mastitis: The mechanistic pathway involves healthy gut microbiota converting CA to DCA, leading to TGR5 activation, cAMP-PKA signaling, inhibition of NF-κB/NLRP3 pathways, and ultimately reduced inflammation and mastitis protection.